Mar Vista Investment Partners LLC Has $35.59 Million Stake in Mettler-Toledo International, Inc. (NYSE:MTD)

Mar Vista Investment Partners LLC decreased its holdings in Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 14.0% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 30,134 shares of the medical instruments supplier's stock after selling 4,903 shares during the quarter. Mettler-Toledo International accounts for about 2.9% of Mar Vista Investment Partners LLC's portfolio, making the stock its 16th largest holding. Mar Vista Investment Partners LLC owned approximately 0.14% of Mettler-Toledo International worth $35,586,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of the business. Farther Finance Advisors LLC grew its position in Mettler-Toledo International by 39.1% during the first quarter. Farther Finance Advisors LLC now owns 89 shares of the medical instruments supplier's stock worth $103,000 after buying an additional 25 shares in the last quarter. QRG Capital Management Inc. grew its position in Mettler-Toledo International by 29.4% during the first quarter. QRG Capital Management Inc. now owns 489 shares of the medical instruments supplier's stock worth $577,000 after buying an additional 111 shares in the last quarter. Wealth Enhancement Advisory Services LLC grew its position in Mettler-Toledo International by 95.0% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 2,202 shares of the medical instruments supplier's stock worth $2,600,000 after buying an additional 1,073 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. grew its position in Mettler-Toledo International by 13.3% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 2,488 shares of the medical instruments supplier's stock worth $2,929,000 after buying an additional 292 shares in the last quarter. Finally, Boston Trust Walden Corp raised its stake in Mettler-Toledo International by 7.1% in the first quarter. Boston Trust Walden Corp now owns 34,610 shares of the medical instruments supplier's stock valued at $40,871,000 after purchasing an additional 2,296 shares in the last quarter. Institutional investors and hedge funds own 95.07% of the company's stock.

Wall Street Analyst Weigh In

A number of research analysts recently commented on the company. Robert W. Baird dropped their price target on Mettler-Toledo International from $1,369.00 to $1,034.00 and set a "neutral" rating for the company in a research note on Tuesday, April 22nd. Barclays assumed coverage on shares of Mettler-Toledo International in a research report on Tuesday, June 24th. They set an "overweight" rating and a $1,325.00 price target on the stock. Wall Street Zen lowered shares of Mettler-Toledo International from a "buy" rating to a "hold" rating in a research report on Monday, May 5th. Bank of America increased their price target on shares of Mettler-Toledo International from $1,200.00 to $1,260.00 and gave the stock a "neutral" rating in a research report on Thursday, June 26th. Finally, Jefferies Financial Group raised Mettler-Toledo International from an "underperform" rating to a "hold" rating and lowered their price target for the stock from $1,200.00 to $1,110.00 in a report on Monday, May 5th. Seven analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat, Mettler-Toledo International presently has a consensus rating of "Hold" and a consensus target price of $1,280.90.

Mettler-Toledo International Stock Down 1.0%

Shares of NYSE:MTD traded down $12.63 during trading on Friday, hitting $1,223.62. 118,779 shares of the company were exchanged, compared to its average volume of 150,365. The business's 50 day moving average is $1,162.86 and its 200-day moving average is $1,195.79. The company has a market capitalization of $25.43 billion, a P/E ratio of 30.51, a price-to-earnings-growth ratio of 3.80 and a beta of 1.37. Mettler-Toledo International, Inc. has a 1-year low of $946.69 and a 1-year high of $1,546.93.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The medical instruments supplier reported $8.19 EPS for the quarter, beating analysts' consensus estimates of $7.90 by $0.29. Mettler-Toledo International had a negative return on equity of 556.22% and a net margin of 22.17%. The firm had revenue of $883.74 million for the quarter, compared to analyst estimates of $876.61 million. During the same period last year, the firm posted $8.89 earnings per share. The business's revenue for the quarter was down 4.6% on a year-over-year basis. As a group, sell-side analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current year.

Insider Buying and Selling

In other Mettler-Toledo International news, Director Michael A. Kelly sold 1,062 shares of Mettler-Toledo International stock in a transaction dated Wednesday, May 28th. The stock was sold at an average price of $1,159.93, for a total transaction of $1,231,845.66. Following the transaction, the director directly owned 120 shares of the company's stock, valued at approximately $139,191.60. The trade was a 89.85% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 1.94% of the company's stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.